79 related articles for article (PubMed ID: 17573820)
1. Splice variation in the cytoplasmic domains of myelin oligodendrocyte glycoprotein affects its cellular localisation and transport.
Boyle LH; Traherne JA; Plotnek G; Ward R; Trowsdale J
J Neurochem; 2007 Sep; 102(6):1853-1862. PubMed ID: 17573820
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis.
Clements CS; Reid HH; Beddoe T; Tynan FE; Perugini MA; Johns TG; Bernard CC; Rossjohn J
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):11059-64. PubMed ID: 12960396
[TBL] [Abstract][Full Text] [Related]
3. Major isoform of zebrafish P0 is a 23.5 kDa myelin glycoprotein expressed in selected white matter tracts of the central nervous system.
Bai Q; Sun M; Stolz DB; Burton EA
J Comp Neurol; 2011 Jun; 519(8):1580-96. PubMed ID: 21452240
[TBL] [Abstract][Full Text] [Related]
4. Preretinal Hemorrhage in Myelin Oligodendrocyte Glycoprotein-Associated Disease.
Sudharshan R; Borchert MS; Chang MY
Ophthalmol Retina; 2023 Dec; 7(12):1108. PubMed ID: 37642629
[No Abstract] [Full Text] [Related]
5. Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report.
Zhang X
Adv Ophthalmol Pract Res; 2021 Dec; 1(2):100025. PubMed ID: 37846324
[No Abstract] [Full Text] [Related]
6. Isolated Ptosis as the Single Clinical Manifestation of Anti-Myelin Oligodendrocyte Glycoprotein Syndrome.
Madureira B; Matos S; Jorge A; Pais I; Pais RP; Correia I; Martins AI; Lemos J
J Neuroophthalmol; 2024 May; ():. PubMed ID: 38689403
[No Abstract] [Full Text] [Related]
7. hnRNP A1 dysfunction alters RNA splicing and drives neurodegeneration in multiple sclerosis (MS).
Salapa HE; Thibault PA; Libner CD; Ding Y; Clarke JWE; Denomy C; Hutchinson C; Abidullah HM; Austin Hammond S; Pastushok L; Vizeacoumar FS; Levin MC
Nat Commun; 2024 Jan; 15(1):356. PubMed ID: 38191621
[TBL] [Abstract][Full Text] [Related]
8. Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders.
Takai Y; Misu T; Fujihara K; Aoki M
Front Neurol; 2023; 14():1209749. PubMed ID: 37545724
[TBL] [Abstract][Full Text] [Related]
9. Increased Plasma Lipocalin-2 Levels in Patients with Myelin Oligodendrocyte Glycoprotein-IgG-Positive Optic Neuritis.
Kim JH; Lee H; Oh J; Suk K; Chun BY
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566760
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium.
Canonica J; Zhao M; Favez T; Gelizé E; Jonet L; Kowalczuk L; Guegan J; Le Menuet D; Viengchareun S; Lombès M; Pussard E; Arsenijevic Y; Behar-Cohen F
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502527
[TBL] [Abstract][Full Text] [Related]
11. Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases.
Schanda K; Peschl P; Lerch M; Seebacher B; Mindorf S; Ritter N; Probst M; Hegen H; Di Pauli F; Wendel EM; Lechner C; Baumann M; Mariotto S; Ferrari S; Saiz A; Farrell M; Leite MIS; Irani SR; Palace J; Lutterotti A; Kümpfel T; Vukusic S; Marignier R; Waters P; Rostasy K; Berger T; Probst C; Höftberger R; Reindl M
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34131067
[TBL] [Abstract][Full Text] [Related]
12. Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice.
Marchionatti A; Woodhall M; Waters PJ; Sato DK
Neurol Sci; 2021 Jan; 42(1):73-80. PubMed ID: 33063216
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in MOG-IgG associated neurological disorders.
Hegen H; Reindl M
Ther Adv Neurol Disord; 2020; 13():1756286420945135. PubMed ID: 33029200
[TBL] [Abstract][Full Text] [Related]
14. Myelin oligodendrocyte glycoprotein antibodies in neurological disease.
Reindl M; Waters P
Nat Rev Neurol; 2019 Feb; 15(2):89-102. PubMed ID: 30559466
[TBL] [Abstract][Full Text] [Related]
15. Pattern Recognition of the Multiple Sclerosis Syndrome.
Zabad RK; Stewart R; Healey KM
Brain Sci; 2017 Oct; 7(10):. PubMed ID: 29064441
[TBL] [Abstract][Full Text] [Related]
16. Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.
Peschl P; Bradl M; Höftberger R; Berger T; Reindl M
Front Immunol; 2017; 8():529. PubMed ID: 28533781
[TBL] [Abstract][Full Text] [Related]
17. The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response.
Afrache H; Gouret P; Ainouche S; Pontarotti P; Olive D
Immunogenetics; 2012 Nov; 64(11):781-94. PubMed ID: 23000944
[TBL] [Abstract][Full Text] [Related]
18. Function of alternative splicing.
Kelemen O; Convertini P; Zhang Z; Wen Y; Shen M; Falaleeva M; Stamm S
Gene; 2013 Feb; 514(1):1-30. PubMed ID: 22909801
[TBL] [Abstract][Full Text] [Related]
19. Population-based study of genetic variation in individuals with autism spectrum disorders from Croatia.
Wang LS; Hranilovic D; Wang K; Lindquist IE; Yurcaba L; Petkovic ZB; Gidaya N; Jernej B; Hakonarson H; Bucan M
BMC Med Genet; 2010 Sep; 11():134. PubMed ID: 20858243
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing in multiple sclerosis and other autoimmune diseases.
Evsyukova I; Somarelli JA; Gregory SG; Garcia-Blanco MA
RNA Biol; 2010; 7(4):462-73. PubMed ID: 20639696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
